Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Salivary Transcriptome Biomarkers for Early Diabetes Detection

NCT02673762 is registered in ClinicalTrials.gov with PeriRx as lead sponsor.

NCT NCT02673762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02673762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Salivary Transcriptome Biomarkers for Early Diabetes Detection
Lead sponsor
PeriRx
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2016
Completion date
February 28, 2019
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, pre-diabetes, type ii diabetes